c-MET
c-MET, also called MET, is a membrane receptor that is essential for embryonic development and wound healing.
Products Related to c-MET(99)
- GC12531Cabozantinib malate (XL184)CAS: 1140909-48-3Purity: >99.50%
Cabozantinib malate (XL184) (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
- GC17715Golvatinib (E7050)CAS: 928037-13-2Purity: >98.00%
Golvatinib (E7050) (E-7050) is a potent dual inhibitor of both c-Met and VEGFR2 kinases with IC50s of 14 and 16 nM, respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC12531 | Cabozantinib malate (XL184) | 1140909-48-3 | >99.50% | |
Cabozantinib malate (XL184) (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively. | ||||
| GC13833 | BMS-794833 | 1174046-72-0 | >99.50% | |
Met/VEGFR-2 inhibitor,potent and ATP-competitive | ||||
| GC17715 | Golvatinib (E7050) | 928037-13-2 | >98.00% | |
Golvatinib (E7050) (E-7050) is a potent dual inhibitor of both c-Met and VEGFR2 kinases with IC50s of 14 and 16 nM, respectively. | ||||